UK economy shrinks in October on month before, missing expectations
(Alliance News) - The UK economy shrank in October and in the three months leading up to October, the Office for National Statistics reported on Friday. Read More
(Alliance News) - The UK economy shrank in October and in the three months leading up to October, the Office for National Statistics reported on Friday. Read More
Volex PLC - Hampshire, England-based maker of power and data transmission products - Dave Webster, the newly installed non-executive chair of Volex, buys 113,096 shares at average 408.34 pence, worth GBP461,816, on Monday, Tuesday and Wednesday. They are Webster's first shares. He was brought in last month amid a leadership shake-up that saw Nat Rothschild move to chief executive from executive chair. Read More
(Alliance News) - Stocks in London are set to open higher on Friday, ahead of UK gross domestic product, trade balance and industrial production data. Read More
(Alliance News) - Welcome to the Alliance News UK service (ISSN 2515-9453), consisting of the Alliance News UK Professional and its family of financial newswires serving investors and their professional advisers. Read More
GSK PLC - London-based pharmaceuticals firm - US Food & Drug Administration approves a supplemental new drug application for gepotidacin as an oral option for adult and paediatric patients from 12 years of age for the treatment of uncomplicated urogenital gonorrhoea. This follows the US FDA approval of gepotidacin earlier this year as an oral treatment for female adult and paediatric patients 12 years of age and older with uncomplicated urinary tract infection. The application was based on positive results from the Eagle-1 phase III trial which demonstrated that gepotidacin was non-inferior to standard of care combination treatment for gonorrhoea. The trial also supported the safety and tolerability profile of gepotidacin, with no serious drug related adverse events observed in either the gepotidacin or the comparator arm. The most common reported adverse reactions were mild to moderate gastrointestinal events. Read More
(Alliance News) - The FTSE 100 forged ahead on Thursday as a less 'hawkish' than feared rate cut by the US Federal Reserve and a brighter US economic outlook spurred stocks, despite some fresh AI worry. Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - CVS Group PLC said it will begin trading on London's Main Market from next month. Read More
(Alliance News) - ACG Metals Ltd on Thursday said it does not plan to make an offer for fellow London-listing Anglo Asian Mining PLC, seeing little opportunity for "value creation" from a deal. Read More
(Alliance News) - Shares in Ceres Power Holdings PLC fell heavily on Thursday after a scathing attack from activist short-seller Grizzly Research. Read More
(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Thursday. Read More
(Alliance News) - RM PLC on Thursday said full-year profit rose sharply, driven by strong growth in its core Assessment division, even as overall revenue dipped amid a challenging UK schools market. Read More
(Alliance News) - Stackbitcointreasury PLC on Thursday reported a jump in its full-year profit due to a sell-down of its core digital asset portfolio, as it appointed a former UK chancellor as executive chair. Read More
(Alliance News) - Tristel PLC on Thursday said it is seeing "strong" volume momentum underpinned by "solid" growth in the UK and accelerating demand across Europe. Read More
(Alliance News) - TwentyFour Select Monthly Income Fund Ltd on Thursday announced a higher net asset value, although the NAV total return was lower than a year ago, and highlighted that the outlook for the credit market is positive. Read More